初级保健中的 Xerostomia:一种基于登记册的研究,研究了患病率,药物类别以及相关的风险因素
Vini Rughwani1, Junmei Miao Jonasson1, Bertil Marklund1
1School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Frontiers in oral health
|October 27, 2025
概括
药物使用,特别是多药,显著增加异口症 (口腔干燥) 的风险,特别是在老年人和女性中. 需要提高临床意识,以更好地检测和管理这种常见的疾病.
科学领域:
- 口腔医学是指口腔医学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 喉干燥 (xerostomia) 是一种常见的疾病,通常与唾液流量减少有关.
- 它是许多药物的常见副作用,也与衰老和女性性别有关.
研究的目的:
- 估计在瑞典Västra Götaland的成年人中异口症的患病率.
- 根据年龄和性别分层,调查异口症与使用的药物的数量和类型之间的关联.
主要方法:
- 在Vega医疗保健数据库中提取了有关异口腔诊断的数据 (ICD 10代码I11.7和R68.2).
- 根据药物类型和数量,年龄和性别分析了患病率.
主要成果:
- 异口症诊断的总体患病率为0.23%.
- 药物使用,特别是多药 (≥5种药物) 强烈与异口症相关,增加了9.68倍的几率 (p < 0.0001).
- 在使用药物治疗代谢,神经系统和心血管疾病的患者中观察到更高的患病率. 女性 (73.08%) 和71岁以上的个人显示出更高的诊断率.
结论:
- 药物使用之间存在显著的关联,特别是多药,和异口症,在年龄,性别和药物类别之间存在差异.
- 尽管风险很高,但在初级医疗保健中,异口症诊断的流行率很低,这表明需要提高临床意识和例行评估.
相关概念视频
Peptic Ulcer Disease IV: Management
428
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
428
Peptic Ulcer Disease I: Introduction
740
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
740
Barrett Esophagus-II: Clinical Manifestations and Management
786
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
786
Gastroesophageal Reflux Disease II: Clinical Features and Management
686
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
686
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
932
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
932


